We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Method for Detection of Breast Arterial Calcifications via Mammograms Indicates Likelihood of Heart Disease

By HospiMedica International staff writers
Posted on 16 Feb 2022

A new method for the detection and quantification of breast arterial calcifications (BACs) has important implications for heart disease risk. More...

Volpara Health (Wellington, New Zealand) has secured a US patent focused on detection of (BACs) via mammograms. BACs are medial calcifications of the mammary arteries (inappropriate and pathological depositions of mineral in the form of calcium phosphate salts). Generally considered as a benign and incidental finding from an oncological perspective, BACs have been demonstrated to be associated with chronic kidney disease, bone mineral density reduction, diabetes mellitus, metabolic syndrome, hypertension, coronary artery disease, and strokes.

Most clinical research correlating BACs with the risk of coronary artery disease has relied on the absence versus presence of BACs, or semi-quantitative BAC metrics with large uncertainty and standard deviation. Consequently, there have been inconsistent findings. That was exactly the same situation as with breast density measurement until researchers made the field much more quantitative and objective by using more automated algorithms. While a commercial software product that can detect and quantify BACs during routine mammographic screening, using this data then predict a patient's risk of heart disease will require further development.

This latest patent - which builds off Volpara Health's approach to quantitative and objective breast density scoring -is a significant advance. Using breast tissue composition and anthropomorphic measures, a tissue composition map that identifies BACs can be created from a mammogram. Subsequently, a score is generated that indicates the likelihood of heart disease resulting from these calcifications.

"This patent is an important advancement in patient care. Being able to quantify breast arterial calcifications has the potential to take what are often considered incidental, insignificant findings on a mammogram, and triage patients to cardiac care and interventions," said Volpara CEO Ralph Highnam.

Related Links:
Volpara Health 


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.